{
  "report_rows": [
    {
      "kpi": "Operating EPS",
      "prediction": "BEAT",
      "answer": "pred $1.91 vs. cons $1.817",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "P&C combined ratio",
      "prediction": "BEAT",
      "answer": "pred 96.6% vs. cons 97.29%",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Net written premium",
      "prediction": "MISS",
      "answer": "pred $2.86B vs. cons $2.895B",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "Commercial pricing/growth commentary (2H26)",
      "prediction": "LOWER",
      "answer": "guide slower/softer vs. cons UNVERIFIED",
      "confidence": "LOW"
    },
    {
      "kpi": "Casualty reserve posture (2H26)",
      "prediction": "UNCHANGED",
      "answer": "guide continued conservatism vs. cons UNVERIFIED",
      "confidence": "LOW"
    },
    {
      "kpi": "Investment-income outlook (2H26)",
      "prediction": "UNCHANGED",
      "answer": "guide solid-growth trajectory vs. cons UNVERIFIED",
      "confidence": "LOW"
    }
  ],
  "day1_residual_pct": -3.0,
  "day1_confidence": "LOW",
  "day5_residual_pct": -3.5,
  "day5_path": "FOLLOW-THROUGH",
  "day5_rationale": "FOLLOW-THROUGH \u2014 weaker forward pricing/growth outweighs a clean current-quarter underwriting beat",
  "day5_confidence": "LOW"
}